The Biology of Ageing: From Hallmarks to Drugs provides a series of reviews covering multiple aspects of the translational pipeline as interventions in the biology of ageing itself become a clinical reality. New chapters cover Cellular senescence and NAD+: what are the links?, Biomarker for ageing: potential and pitfalls, What chemists offer to ageing research, You are what you eat - or are you? Exploring dietary versus topical anti-oxidants in skin ageing, Clinical trials: A simple guide for gerontologists, Towards an ethical framework for geroscience, and more.
The book explores links between known ageing mechanisms and new interventions, agents and actions at the nutraceutical-drug divide, the challenges and opportunities provided by biomarkers and chemistry- biology interface and lastly the ethical and operational challenges of clinical trials in the age of translational geroscience.
- Covers novel mechanistic ideas
- Includes ethical and industrial input
- Focuses on problems and solutions from chemistry and biomarkers to the clinic
Sprache
Verlagsort
Verlagsgruppe
Elsevier Science & Techn.
Dateigröße
ISBN-13
978-0-443-19279-1 (9780443192791)
Schweitzer Klassifikation
PrefaceRichard Faragher1. Cellular senescence and NAD+: what are the links?Sophia Quigley2. Biomarker for ageing: potential and pitfallsLynne Cox3. What chemists offer to ageing researchRichard Hartley4. You are what you eat - or are you? Exploring dietary versus topical anti-oxidants in skin ageingOliver Dillon5. Clinical trials: A simple guide for gerontologistsSimona Reed6. Towards an ethical framework for geroscienceRichard Faragher
